140 related articles for article (PubMed ID: 17294608)
1. Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms.
Parmenter BA; Denney DR; Lynch SG; Middleton LS; Harlan LM
Mult Scler; 2007 Jan; 13(1):25-32. PubMed ID: 17294608
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
3. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM
Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
[TBL] [Abstract][Full Text] [Related]
4. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.
Savettieri G; Messina D; Andreoli V; Bonavita S; Caltagirone C; Cittadella R; Farina D; Fazio MC; Girlanda P; Le Pira F; Liguori M; Lugaresi A; Nocentini U; Reggio A; Salemi G; Tedeschi G; Trojano M; Valentino P; Quattrone A
J Neurol; 2004 Oct; 251(10):1208-14. PubMed ID: 15503099
[TBL] [Abstract][Full Text] [Related]
5. APOE epsilon4 and the cognitive genetics of multiple sclerosis.
Ghaffar O; Reis M; Pennell N; O'Connor P; Feinstein A
Neurology; 2010 May; 74(20):1611-8. PubMed ID: 20479360
[TBL] [Abstract][Full Text] [Related]
6. APOE and risk of cognitive impairment in multiple sclerosis.
Oliveri RL; Cittadella R; Sibilia G; Manna I; Valentino P; Gambardella A; Aguglia U; Zappia M; Romeo N; Andreoli V; Bono F; Caracciolo M; Quattrone A
Acta Neurol Scand; 1999 Nov; 100(5):290-5. PubMed ID: 10536914
[TBL] [Abstract][Full Text] [Related]
7. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
Tamam Y; Tasdemir N; Yalman M; Tamam B
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
[TBL] [Abstract][Full Text] [Related]
8. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
9. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
[TBL] [Abstract][Full Text] [Related]
10. Association between ApoE epsilon4 and cognitive impairment after stroke.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
[TBL] [Abstract][Full Text] [Related]
11. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
12. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Martins CA; Oulhaj A; de Jager CA; Williams JH
Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
[TBL] [Abstract][Full Text] [Related]
13. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Rafiei M; Zarif Yeganeh M; Sheikholeslami S; Gozalpour E; Ghaffarpour M; Hedayati M
J Neurol Sci; 2012 Sep; 320(1-2):22-5. PubMed ID: 22698480
[TBL] [Abstract][Full Text] [Related]
15. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
[TBL] [Abstract][Full Text] [Related]
16. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
17. Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects.
Norberg J; Graff C; Almkvist O; Ewers M; Frisoni GB; Frölich L; Hampel H; Jones RW; Kehoe PG; Lenoir H; Minthon L; Nobili F; Olde Rikkert M; Rigaud AS; Scheltens P; Soininen H; Spiru L; Tsolaki M; Wahlund LO; Vellas B; Wilcock G; Elias-Sonnenschein LS; Verhey FR; Visser PJ
Dement Geriatr Cogn Disord; 2011; 32(2):135-42. PubMed ID: 21952537
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism carriers exhibit objective cognitive deficits: a single center trial.
Zeng Y; Huang X; Elkin K; Stone C; Rajah GB; Guan L; Du H; Geng X
Neurol Res; 2020 Aug; 42(8):676-682. PubMed ID: 32634047
[TBL] [Abstract][Full Text] [Related]
19. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM
Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690
[TBL] [Abstract][Full Text] [Related]
20. Association of APOE polymorphisms with disease severity in MS is limited to women.
Kantarci OH; Hebrink DD; Achenbach SJ; Pittock SJ; Altintas A; Schaefer-Klein JL; Atkinson EJ; De Andrade M; McMurray CT; Rodriguez M; Weinshenker BG
Neurology; 2004 Mar; 62(5):811-4. PubMed ID: 15007140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
